Method for predicting responsiveness to a pharmaceutical therapy for obesity

Details for Australian Patent Application No. 2008343177 (hide)

Owner Eli Lilly and Company

Inventors Leohr, Jennifer K.

Agent Spruson & Ferguson

Pub. Number AU-A-2008343177

PCT Pub. Number WO2009/085917

Priority 61/014,881 19.12.07 US

Filing date 18 December 2008

Wipo publication date 9 July 2009

International Classifications

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/085917 Priority application(s): WO2009/085917

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343181-Food product including one or more omega-3 fatty acids and one or more fruit flavors

2008343174-Food product including one or more encapsulated omega-3 fatty acids and one or more fruit flavors